Bacterial tyrosine kinases: novel targets for antibacterial therapy?

Alain J Cozzone1

  • 1Institute of Biology and Chemistry of Proteins, University of Lyon, 7 passage du Vercors, 69007 Lyon, France. aj.cozzone@ibcp.fr

Trends in Microbiology
|October 27, 2009
PubMed

Insights

Bacterial resistance to antibiotics is a major health issue. Protein tyrosine phosphorylation regulates bacterial processes, offering new targets for developing novel antibacterial drugs.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Antibiotic resistance in pathogenic bacteria poses a significant global health threat.
  • Novel antibacterial agents with new mechanisms of action are urgently needed.
  • Bacterial survival and virulence are increasingly understood to be regulated by protein phosphorylation.

Purpose of the Study:

  • To review recent findings on the role of protein tyrosine phosphorylation in bacterial physiology.
  • To explore the potential of targeting protein tyrosine kinases for novel antibiotic development.

Main Methods:

  • Literature review of recent research on bacterial protein tyrosine phosphorylation.
  • Analysis of studies demonstrating the impact of phosphorylation on bacterial processes.
  • Identification of potential therapeutic targets within bacterial tyrosine kinase pathways.

Main Results:

  • Protein tyrosine phosphorylation plays a critical role in regulating essential bacterial cellular processes.
  • Specific tyrosine kinases are key regulators of bacterial survival and virulence.
  • These findings highlight conserved mechanisms across different bacterial species.

Conclusions:

  • Protein tyrosine phosphorylation is a central regulatory mechanism in bacterial physiology.
  • Targeting bacterial protein tyrosine kinases presents a promising strategy for discovering new antibiotics.
  • Further research into these pathways could lead to effective treatments against resistant bacteria.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...